The document provides guidelines for the management and treatment of malaria cases in India. It outlines that the first priority is clinical management to reduce morbidity and mortality. It then describes appropriate treatment for malaria depending on the level of facility, from large hospitals with intensive care capabilities to small hospitals with more limited resources. It provides detailed treatment guidelines for both adults and children based on severity of symptoms and malaria risk of the area. It also discusses disease control strategies like case detection, treatment, mass drug administration, and chemoprophylaxis.

2. Control of malaria

4. MANAGEMENT:

19. PRIMAQUINE:

20. CHLOROQUINE: EACH TAB CONTAINS 150MG(BASE) AGE(YRS) DAY 1 DAY 2 DAY 3 <1 ½ ½ ¼ 1-4 1 1 ½ 5-8 2 2 1 9-14 3 3 1 ½ >15 4 4 2

21. PRIMAQUINE- P.FALCIPARUM GIVEN AS SINGLE DOSE ON DAY ONE AGE(YRS) MG BASE NO OF TABLETS <1 - - 1-4 7.5 1 5-8 15 2 9-14 30 4 >15 45 6

22. PRIMAQUINE- P.VIVAX GIVEN FOR 14 DAYS AGE(YRS) MG BASE NO OF TABLETS <1 - - 1-4 2-5 1 5-8 5 2 9-14 10 4 >15 15 6

23. ACT:ARTESUNATE+ SUFADOXINE/PYRIMETHAMINE EACH TAB OF: ARTESUNATE CONTAINS 50MG ARTESUNATE S/P CONTAINS 500MG SULFADOXINE+ 25MG PYRIMETHAMINE NOT RECOMMENDED IN PREGNANCY OTHER COMBINATIONS:ATRESUNATE+MEFLOQUINE ARTEMETHER+LUMEFANTRINE AGE(YRS) DAY 1 DAY 2 DAY 3 <1 ½+ ¼ ½ +- ½ +- 1-4 1 + 1 1+- 1+- 5-8 2+1 ½ 2+- 2+- 9-14 3+2 3+- 3+- >15 4+3 4+- 4+-

24. NO RDK,MICROSCOPY AVAILABLE: LOW RISK AREA

25. NO RDK,MICROSCOPY AVAILABLE:HIGH RISK AREA:

34. CHEMOPROPHYLAXIS: DRUG THERAPEUTIC DOSE PROPHYLAXIS CHLOROQUINE 100/150 MG BASE 300MG PROGUANIL 100 MG 200MG 2 TAB OD MEFLOQUINE 250 MG 250MG 1/WEEK(SAME ADY EACH WEEK DOXYCYCLINE 100 MG 100MG 1 CAP OD